To validate the significance of differential expression of TGM2, a total of 82 meningioma samples were immunostained with a TGM2 antibody and quantified by microscopy under a 400X high power field (HPF) system (illustrated in Figure 2A and 2B). Here, TGM2 is linked to meningioma.